Caricamento...
Role of BRAF in Hepatocellular Carcinoma: A Rationale for Future Targeted Cancer Therapies
The few therapeutic strategies for advance hepatocellular carcinoma (HCC) on poor knowledge of its biology. For several years, sorafenib, a tyrosine kinase inhibitors (TKI) inhibitor, has been the approved treatment option, to date, for advanced HCC patients. Its activity is the inhibition of the re...
Salvato in:
| Pubblicato in: | Medicina (Kaunas) |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6956203/ https://ncbi.nlm.nih.gov/pubmed/31766556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicina55120754 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|